Satenig Y Guler

In vivo validation of thymidylate kinase (TMK) with a rationally designed, selective antibacterial compound.

Diane Joseph-McCarthy, Sameer Kawatkar, D. Joseph-McCarthy, 2012, ACS chemical biology.

Antibacterial inhibitors of Gram-positive thymidylate kinase: structure-activity relationships and chiral preference of a new hydrophobic binding region.

T. Keating, Gabriel Martínez-Botella, John N Breen, 2014, Journal of medicinal chemistry.

ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii

D. Ehmann, S. McLeod, Camilo Velez-Vega, 2017, Nature Microbiology.

Selective inhibitors of tumor progression loci-2 (Tpl2) kinase with potent inhibition of TNF-alpha production in human whole blood.

J. Telliez, Lih-Ling Lin, Junjun Wu, 2009, Bioorganic & medicinal chemistry letters.

Rational design of a new antibiotic class for drug-resistant infections

S. McLeod, A. Ferguson, G. Drusano, 2021, Nature.

Inhibitors of tumor progression loci-2 (Tpl2) kinase and tumor necrosis factor alpha (TNF-alpha) production: selectivity and in vivo antiinflammatory activity of novel 8-substituted-4-anilino-6-aminoquinoline-3-carbonitriles.

D. Joseph-McCarthy, J. Telliez, J. Cuozzo, 2007, Journal of medicinal chemistry.

Discovery of selective and potent inhibitors of gram-positive bacterial thymidylate kinase (TMK).

Diane Joseph-McCarthy, Jon Read, Sameer Kawatkar, 2012, Journal of medicinal chemistry.